Oncology professionals from around the globe are at the 2018 ASCO Annual Meeting. Today’s key research highlights address the connection between microsatellite instability and Lynch syndrome, a blood test that may be used to find early lung cancer, a new targeted therapy for treating advanced breast cancer, an immunotherapy-chemotherapy combination that slows lung cancer growth, and evidence that personalized medicine helps people with cancer live longer.

Read key research highlights that will be presented at the 2018 ASCO Annual Meeting, including monitoring symptoms with technology, screening and genomic testing for lung cancer, and new treatment regimens for breast cancer and T-cell leukemia and lymphoma.

In this month’s From the Editor’s Desk, Dr. Schapira writes about prevention and what we can do to help understand and manage our personal cancer risk.

The 2018 Clinical Cancer Advances report of the American Society of Clinical Oncology has crowned an adoptive cell immunotherapy as its Advance of the Year. What is this innovative cancer treatment? What are the risks and benefits?

Did you know that scientists can use samples from our bodies to learn more about cancer and how to treat it? These samples are called biospecimens, and people can donate them to help make progress in cancer research regardless of whether they have cancer.

In this podcast, Cancer.Net Associate Editor Ezra Cohen, MD, FRCPC, discusses some of the key themes that arose at the 2017 3rd World Congress on Thyroid Cancer.

Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Research released today covers how using a web-based system to report symptoms helps patients live longer, a shorter schedule of chemotherapy can be an option for certain people with colon cancer, and a targeted therapy may slow the growth of BRCA-related breast cancer.

Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Research highlights from today include pregnancy after breast cancer, abiraterone for prostate cancer, a new medication that targets a rare genetic abnormality, new blood test technology for cancer screening, and genomic testing.

In this podcast, certified genetic counselor Tiffani DeMarco answers common questions about genetic counseling and explains what the future may hold for genetic testing.

Genetic testing can identify inherited risks for some types of cancer. The results of these tests affect both you and your family. Here are some things to think about when sharing genetic test results.